Navigation Links
ANI Pharmaceuticals, Inc. Announces Date for Second Quarter 2013 Earnings Release
Date:7/22/2013

statement, whether as a result of new information, future events or otherwise.

For more information about ANI, please contact:
Arthur S. Przybyl
(218) 634-3608
arthur.przybyl@anipharmaceuticals.com


'/>"/>
SOURCE ANI Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
2. Provectus Pharmaceuticals, Inc.s Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
3. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
4. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
5. Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference
6. Depomed Announces Receipt of $1 million Milestone Payment From Ironwood Pharmaceuticals, Inc.
7. Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim
8. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
9. Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012
10. Hybrid Fuels, Inc. Announces Name Change to Nouveau Life Pharmaceuticals, Inc.
11. Debiopharm and Ascepion Pharmaceuticals, Inc. Announce an Exclusive License Agreement for the Development and Commercialisation of the Dual-Targeting Kinase Inhibitor, ASP-08126 (Debio 1144), for the Treatment of Oncology Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Sept. 22, 2014 Children,s National Health ... Sept. 29 at 5 p.m. EDT for its ... in response to continued strong interest from inventors.  ... will be awarded to the winning presentations at ... Symposium hosted by Children,s National in October. For ...
(Date:9/22/2014)... 22, 2014 Persistence Market Research ... Market Study on Ophthalmic Devices: Asia ... devices market was valued at USD 29,171.5 million in 2014 ... 6.5% from 2014 to 2020, to reach an estimated ... Browse the full Global Market Study on Ophthalmic Devices:  ...
(Date:9/22/2014)... , Sept. 22, 2014 /CNW/ - T-Bird Pharma ... focused on developing premium quality medical marijuana products, is ... Biomedical Inc. ("Thunderbird"), has signed a definitive lease agreement ... , BC.  The facility has 28,966 square feet ... 14,500 square feet of mezzanine space for a total ...
Breaking Medicine Technology:Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 3Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 2Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 3Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 4Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 5T-Bird Pharma Inc. to Increase Growing Capacity with Expansion into a 43,500 square feet Second Facility 2T-Bird Pharma Inc. to Increase Growing Capacity with Expansion into a 43,500 square feet Second Facility 3
... CPF Calls on Manufacturer and FDA to Expedite Review of ... The Coalition for Pulmonary Fibrosis (CPF) is calling this a ... a pivotal Phase III clinical trial is completed for Pirfenidone ... way for the first FDA-approved therapy to treat PF - ...
... Intellectual property based on breakthrough research from a ... Montreal Heart Institute Research Centre, Canada.TOULOUSE, France and ... SA (Cerenis), a privately held pharmaceutical company developing ... metabolic diseases, today announced that it has in-licensed ...
Cached Medicine Technology:Positive Data From Lung Study May Lead to First FDA Approved Treatment for Pulmonary Fibrosis 2Positive Data From Lung Study May Lead to First FDA Approved Treatment for Pulmonary Fibrosis 3Cerenis Therapeutics In-Licenses Intellectual Property for New Treatment of Aortic Valve Stenosis 2
(Date:9/22/2014)... Amy Norton HealthDay Reporter ... fare better when newborn intensive care units (NICU) set up ... a new study finds. Researchers at one children,s hospital ... were less distressed when their NICU switched from the traditional ... published online Sept. 22 in the journal Pediatrics , ...
(Date:9/22/2014)... a founding partner in the Global STEM Alliance, a ... talent in science, technology, engineering and math (STEM) around ... of Sciences (NYAS), Malaysian Prime Minister Najib Razak participated ... , With the goal of developing over 1,000,000 aspiring ... the initiative will create a host of learning opportunities, ...
(Date:9/22/2014)... Recent two-generation approaches to reducing poverty that help ... from researchers, advocates, and foundations. By combining education ... move to jobs that offer a path out ... for children, these programs aim to improve the ... a new report from the National Center for ...
(Date:9/22/2014)... York, New York (PRWEB) September 22, 2014 ... associated with the use of power morcellators ( ... LLP notes a new report detailing the continued ... warnings from federal regulators that specifically discouraged these ... physicians believe that the potential cancer risks associated ...
(Date:9/22/2014)... Shippensburg, PA (PRWEB) September 22, 2014 Pain ... Your Chronic Pain” is a user- and reader-friendly book designed ... way back to pain-free living. This inspirational book is written ... and desires to know a way to regain a pain-free ... the prison of chronic pain. , Chronic pain has become ...
Breaking Medicine News(10 mins):Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 2Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 3Health News:Growing scientists: World's future jobs are rooted in STEM 2Health News:Growing scientists: World's future jobs are rooted in STEM 3Health News:A two-generation lens: Current state policies fail to support families with young children 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 4Health News:Naturopathic Doctor Inspires and Guides Those Who Suffer with Chronic Pain, Pointing the Way Back to Pain-free Living 2
... drug safely , , THURSDAY, Dec. 13 (HealthDay News) -- For ... Administration advisers have voted to deny Merck & Co.,s request ... , In a 10 to 2 vote with one abstention, ... complicated for consumers to determine on their own if they ...
... YORK (Dec. 13, 2007) -- A leading authority ... of NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New ... for Innovation in Neuroscience from the Society for ... scientists who study the brain and nervous system. ...
... dangerous side effects, including heart trouble , , THURSDAY, Dec. ... and Andy Pettitte, Houston Astros All-Star shortstop Miguel Tejada ... big-name players cited in a highly anticipated report into ... , The report climaxed a 20-month probe by ...
... Robert Klaus, President and CEO of,Chicago-based Oral ... Advocacy Award from the Friends of the National ... Klaus,s contributions on behalf of oral health have ... Peter Anas,Executive Director, NIDCR. "He has approached oral ...
... Make Informed Decisions When Choosing,Nutritional Products, ... news,stories on steroid use in sports continue ... and sports nutrition products for banned,substances. NSF ... solution for athletes, coaches, trainers and anyone,concerned ...
... Repligen Corporation,(Nasdaq: RGEN ) announced today ... to its Board of Directors. Dr. Henry is ... expertise in the,development of therapeutics for disorders affecting ... to welcome an executive with Earl,s industry,knowledge and ...
Cached Medicine News:Health News:FDA Advisers Reject Over-the-Counter Statin 2Health News:FDA Advisers Reject Over-the-Counter Statin 3Health News:FDA Advisers Reject Over-the-Counter Statin 4Health News:Dr. Nicholas Schiff receives research award for Innovation in Neuroscience 2Health News:Report Finds 'Widespread Steroid Use in Baseball' 2Health News:Report Finds 'Widespread Steroid Use in Baseball' 3Health News:Oral Health America's Robert Klaus Honored for Outstanding Public Advocacy 2Health News:Recent Reports Underscore the Importance of Testing Supplements for Athletic Banned Substances 2Health News:Recent Reports Underscore the Importance of Testing Supplements for Athletic Banned Substances 3Health News:Repligen Elects Earl Henry, M.D. to the Board of Directors 2Health News:Repligen Elects Earl Henry, M.D. to the Board of Directors 3
... and high power negative lens delivering magnification ... benefit of this system is ease of ... made possible due to a superior depth ... and individual interpupillary adjustment provides stability for ...
... represents a breakthrough for patients experiencing degenerative ... system gathers bone during decompression, bone bed ... into the implant's chamber produces a local ... the iliac crest. The BAK/C implant is ...
Inside and out, the Achieva is designed to unleash a new era, in which the clinical capabilities of MR will further expand....
Signa Profile is built on the Signa foundation to deliver speed & image quality....
Medicine Products: